Home » Contact
GES holds a South African Products Health Regulatory Authority (SAHPRA) manufacturing authorization (License No: 1401.-.2) that authorises us in accordance to Section 22C(1)(b) of the Medicines and Related substances Act, 1965 (Act 101 of 1965) to import, export, manufacture, pack, label and distribute cannabinoid containing products as well as a GMP certificate (26/7/3/31/1/G0053/2023). We also hold a written confirmation of GMP for export of active substances into the European Union for medicinal products for human use, in accordance with Article 46b(2)(b) of Directive 2001/83/EC.
a. Bulk Active Pharmaceutical Ingredient (API) containing cannabinoids and isolates, including Dronabinol
b. Formulated Dronabinol oily drops
c. Formulated CBD and THC oily drops
d. Pre-filled API CBD and THC cartridges
e. Pre-filled API Syringes
f. Packaging and labelling of manufactured products
g. Re-labelling or redressing
h. Cartoning or secondary packaging
i. Analytical testing
j. Stability testing
k. Bulk distribution
l. Fine distribution
m. Import: API
n. Export: all manufactured products
GES does not own any brands globally with most of our resources focussed on ensuring our clients have the best possible product for their brand. By private label we offer a service where we can custom bespoke client-specific products and formulations from start to finish including packaging. This will be contract manufactured and not sold to anyone else under that formulation and brand. White labelling at GES refers to GES developed products that we can put our clients brand on. These are products that are often “ready to go” and simply require a clients artwork to be placed on the product and exported to the desired market.
Receive our company updates straight to your inbox.
By submitting your details you agree to receive news and company updates from GESLabs.
Specialized biotech company providing therapeutic actives derived from cannabinoids found in medical cannabis.
Leave your details below to receive our product catalogue
By submitting your details you agree to receive news and company updates from GESLabs.
Parameters
|
Specification
|
---|---|
Formulation
|
>98% CBD
|
Appearance
|
White crystalline powder
|
Packaging
|
1kg HDPE container
|
Storage
|
Tightly closed, protected from light, 15 - 25° C
|
Shelf Life
|
24-months (stability ongoing)
|
Extraction
|
Ethanol
|
Origin
|
South Africa
|
Stability Status
|
Conducted according to ICH stability guidelines
Long term studies up to: 24 months (25°C±2°C, 60% ± 5%RH) Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH) |
Parameters
|
Specification
|
---|---|
Formulation
|
400-440/800-880 mg THC distillate + Chemovar terpene concentration
|
Appearance
|
Yellow-gold viscous liquid, solid at room temperature
|
Packaging
|
1ml SS316 or All-Ceramic 10-Thread cartridge
0.5ml SS316 or All-Ceramic 10-Thread cartridge |
Storage
|
Tightly closed, protected from light, 15 - 25° C
|
Shelf Life
|
12 months
|
Extraction
|
Cryo-ethanol extraction
Low temperature Decarboxylation to preserve terpenes |
Origin
|
South Africa
|
Stability Status
|
Conducted according to ICH stability guidelines
Long term studies up to: 12 months (25°C±2°C, 60% ± 5%RH) Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH) |
Parameters
|
Specification
|
---|---|
Formulation
|
400-440/800-880mg THC distillate + Botanical terpene concentration
|
Appearance
|
Yellow-gold viscous liquid, solid at room temperature
|
Packaging
|
1ml SS316 or All-Ceramic 10-Thread cartridge
0.5ml SS316 or All-Ceramic 10-Thread cartridge |
Storage
|
Tightly closed, protected from light, 15 - 25° C
|
Shelf Life
|
12 months
|
Extraction
|
Cryo-ethanol extraction
Low temperature Decarboxylation to preserve terpenes |
Origin
|
South Africa
|
Stability Status
|
Conducted according to ICH stability guidelines
Long term studies up to: 12 months (25°C±2°C, 60% ± 5%RH) Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH) |
Parameters
|
Specification
|
---|---|
Formulation
|
400/800mg THC Live Rosin concentration
|
Appearance
|
Yellow-gold viscous liquid, solid at room temperature
|
Packaging
|
1ml All-Ceramic 510-Thread Cartridge
0.5ml All-Ceramic 510-Thread Cartridge |
Storage
|
Tightly closed, protected from light, 15 - 25° C
|
Shelf Life
|
12 months
|
Extraction
|
EP-grade water and low temperature pressing, fresh frozen cannabis flower
|
Origin
|
South Africa
|
Stability Status
|
Conducted according to ICH stability guidelines
Long term studies up to: 12 months (25°C±2°C, 60% ± 5%RH) Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH) |
Parameters
|
Specification
|
---|---|
Formulation
|
400/800mg THC Live Resin concentration
|
Appearance
|
Yellow-gold viscous liquid, solid at room temperature
|
Packaging
|
1ml All-Ceramic 510-Thread Cartridge
0.5ml All-Ceramic 510-Thread Cartridge |
Storage
|
Tightly closed, protected from light, 15 - 25° C
|
Shelf Life
|
12 months
|
Extraction
|
Low temperature hydrocarbon, fresh frozen cannabis flower
|
Origin
|
South Africa
|
Stability Status
|
Conducted according to ICH stability guidelines
Long term studies up to: 12 months (25°C±2°C, 60% ± 5%RH) Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH) |
Parameters
|
Specification
|
---|---|
Formulation
|
>70% THC <2% CBD
|
Appearance
|
Dark Amber liquid, solid at room temperature
|
Packaging
|
Insert Argon purged. Amber glass bottle 50ml, 500ml and 2.5L. Glass Type III Polypropylene (PE) Cap
|
Storage
|
Tightly closed, protected from light, 15 - 25° C
|
Shelf Life
|
24-months (stability ongoing)
|
Extraction
|
Cryo-ethanol extraction
Low temperature Decarboxylation to preserve terpenes |
Origin
|
South Africa
|
Stability Status
|
Conducted according to ICH stability guidelines
Long term studies up to: 24 months (25°C±2°C, 60% ± 5%RH) Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH) |
Strains
|
Black Cherry Punch (Hybrid-Indica), Blueberry Kush (Indica), Critical Kush (Indica), Creamy Kees (Hybrid-Indica), Royal Go- rilla (Hybrid-Sativa), Karel’s Haze (Hybrid-Sativa), Bafokeng Choice-White Lemon (Hybrid-Sativa), UK Cheese (Sativa), Original Blitz (Indica) | *More strains on request
|
Parameters
|
Specification
|
---|---|
Formulation
|
>88% THC <2% CBD
|
Appearance
|
Clear yellow-gold viscous liquid, solid at room temperature
|
Packaging
|
Insert Argon purged. Amber glass bottle 50ml, 500ml and 2.5L. Glass Type III Polypropylene (PE) Cap
|
Storage
|
Tightly closed, protected from light, 15 - 25° C
|
Shelf Life
|
24-months (stability ongoing)
|
Extraction
|
Cryo-ethanol extraction
Low temperature Decarboxylation to preserve terpenes |
Origin
|
South Africa
|
Stability Status
|
Conducted according to ICH stability guidelines
Long term studies up to: 24 months (25°C±2°C, 60% ± 5%RH) Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH) |
Strains
|
Black Cherry Punch (Hybrid-Indica), Blueberry Kush (Indica), Critical Kush (Indica), Creamy Kees (Hybrid-Indica), Royal Go- rilla (Hybrid-Sativa), Karel’s Haze (Hybrid-Sativa), Bafokeng Choice-White Lemon (Hybrid-Sativa), UK Cheese (Sativa), Original Blitz (Indica)| More strains on request
|
Parameters
|
Specification
|
---|---|
Formulation
|
>70% THC <2% CBD
|
Appearance
|
Viscous semi-solid at room temperature, yellow-gold
|
Packaging
|
Insert Argon purged. Amber glass bottle 50ml, 500ml and 2.5L. Glass Type III Polypropylene (PE) Cap
|
Storage
|
Tightly closed, protected from light, 15 - 25° C
|
Shelf Life
|
24-months (stability ongoing)
|
Extraction
|
Low temperature EP-grade water, fresh frozen cannabis
|
Origin
|
South Africa
|
Stability Status
|
Conducted according to ICH stability guidelines
Long term studies up to: 24 months (25°C±2°C, 60% ± 5%RH) Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH) |
Strains
|
Available on request
|
Parameters
|
Specification
|
---|---|
Formulation
|
> 85% THC <2% THC
|
Appearance
|
Yellow-gold, semi-solid at room temperature
|
Packaging
|
Insert Argon purged. Amber glass bottle 50ml, 500ml and 2.5L. Glass Type III Polypropylene (PE) Cap
|
Storage
|
Tightly closed, protected from light, 15 - 25° C
|
Shelf Life
|
24-months (stability ongoing)
|
Extraction
|
Low temperature hydrocarbon, fresh frozen cannabis flower
|
Origin
|
South Africa
|
Stability Status
|
Conducted according to ICH stability guidelines
Long term studies up to: 24 months (25°C±2°C, 60% ± 5%RH) Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH) |
Strains
|
Available on request
|
Parameters
|
Specification
|
---|---|
Formulation
|
> 95% THC, minors according to DAC monograph
|
Product Type
|
Dronabinol API
|
Appearance
|
Clear viscous liquid, solid at room temperature
|
Packaging
|
Insert Argon purged. Amber glass bottle 50ml, 500ml and 2.5L. Glass Type III Polypropylene (PE) Cap
|
Storage
|
Tightly closed, protected from light, 15 - 25° C
|
Shelf Life
|
12-months
|
Extraction
|
Solvent extraction
|
Origin
|
South Africa
|
Stability Status
|
Conducted according to ICH stability guidelines
Long term studies up to: 12 months (25°C±2°C, 60% ± 5%RH) Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH) |
THC: 30%
THC: 27%
THC: 27%
THC: 26%
* More available on request
Parameters
|
Specification
|
---|---|
Formulation
|
Full spectrum CBD extract with pharma grade MCT oil
|
Product Type
|
MCT oral formulation
|
Appearance
|
Clear to amber liquid at room temperature
|
Packaging
|
30ml amber dropper bottle with a child-resistant lid and syringe
|
Storage
|
Tightly closed, protected from light, 15 - 25° C
|
Shelf Life
|
12-months
|
Extraction
|
Cryo-ethanol extraction
|
Origin
|
South Africa
|
Stability Status
|
Conducted according to ICH stability guidelines
Long term studies up to: 24 months (25°C±2°C, 60% ± 5%RH) Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH) |
Parameters
|
Specification
|
---|---|
Formulation
|
Full spectrum CBD extract with pharma grade MCT oil
|
Product Type
|
MCT oral formulation
|
Appearance
|
Clear to amber liquid at room temperature
|
Packaging
|
30ml amber dropper bottle with a child-resistant lid and syringe
|
Storage
|
Tightly closed, protected from light, 15 - 25° C
|
Shelf Life
|
12-months
|
Extraction
|
Cryo-ethanol extraction
|
Origin
|
South Africa
|
Stability Status
|
Conducted according to ICH stability guidelines
Long term studies up to: 24 months (25°C±2°C, 60% ± 5%RH) Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH) |
200mg/ml CBD <ND THC – 30ml
Parameters
|
Specification
|
---|---|
Formulation
|
CBD isolate with pharma grade MCT oil
|
Product Type
|
MCT oral formulation
|
Appearance
|
Clear to amber liquid at room temperature
|
Packaging
|
30ml amber bottle with glass pipette dropper
|
Storage
|
Tightly closed, protected from light, 15 - 25° C
|
Shelf Life
|
12-months
|
Extraction
|
Cryo-ethanol extraction
|
Origin
|
South Africa
|
Stability Status
|
Conducted according to ICH stability guidelines
Long term studies up to: 24 months (25°C±2°C, 60% ± 5%RH) Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH) |
Parameters
|
Specification
|
---|---|
Formulation
|
Full spectrum THC and CBD extract with pharma grade MCT oil
|
Product Type
|
Oral MCT formulation
|
Appearance
|
Clear to amber liquid at room temperature
|
Packaging
|
30ml amber bottle with child-resistant lid and 1ml syringe
|
Storage
|
Tightly closed, protected from light, 15 - 25° C
|
Shelf Life
|
12-months
|
Extraction
|
Cryo-ethanol extraction
|
Origin
|
South Africa
|
Stability Status
|
Conducted according to ICH stability guidelines
Long term studies up to: 24 months (25°C±2°C, 60% ± 5%RH) Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH) |
25mg/ml CBD – 25mg/ml THC – 30ml
Parameters
|
Specification
|
---|---|
Formulation
|
Full spectrum THC and CBD extract with pharma grade MCT oil
|
Product Type
|
Oral MCT formulation
|
Appearance
|
Clear to amber liquid at room temperature
|
Packaging
|
30ml amber bottle with child-resistant lid and 1ml syringe
|
Storage
|
Tightly closed, protected from light, 15 - 25° C
|
Shelf Life
|
12-months
|
Extraction
|
Cryo-ethanol extraction
|
Origin
|
South Africa
|
Stability Status
|
Conducted according to ICH stability guidelines
Long term studies up to: 24 months (25°C±2°C, 60% ± 5%RH) Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH) |
<1mg/ml CBD -15mg/ml THC – 50ml
Parameters
|
Specification
|
---|---|
Formulation
|
Full spectrum THC extract with pharma grade MCT oil
|
Product Type
|
Oral MCT formulation
|
Appearance
|
Clear viscous liquid, solid a room temperature
|
Packaging
|
50ml amber bottle with child-resistant lid and 1ml syringe
|
Storage
|
Tightly closed, protected from light, 15 - 25° C
|
Shelf Life
|
12-months
|
Extraction
|
Cryo-ethanol extraction
|
Origin
|
South Africa
|
Stability Status
|
Conducted according to ICH stability guidelines
Long term studies up to: 24 months (25°C±2°C, 60% ± 5%RH) Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH) |
Parameters
|
Specification
|
---|---|
Formulation
|
> 95% THC, minors according to DAC monograph
|
Product Type
|
DAC Dronabinol in oily base, MCT-oil formulated according to NRF 22.8
|
Appearance
|
Clear viscous liquid, solid a room temperature
|
Packaging
|
Insert Argon purged. Amber glass bottle 50ml, 500ml and 2.5L. Glass Type III Polypropylene (PE) Cap
|
Storage
|
Tightly closed, protected from light, 15 - 25° C
|
Shelf Life
|
12-months
|
Extraction
|
Cryo-ethanol extraction
Chromatography purification |
Origin
|
South Africa
|
Stability Status
|
Conducted according to ICH stability guidelines
Long term studies up to: 24 months (25°C±2°C, 60% ± 5%RH) Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH) |
Parameters
|
Specification
|
---|---|
Product Type
|
DAC Dronabinol in oily base, MCT-Oil Formulated according to NRF 22.8
|
Formulation
|
25mg/ml DAC Dronabinol
|
Appearance
|
Clear, almost colourless to slightly yellowish viscous solution
|
Packaging
|
50ml, 200ml or 500ml amber glass jar Type III, white CR screw cap, magisterial preparation format with TE cap (PP), 2 x THC strip, reaction tube, sterile pipett
|
Storage
|
Tightly closed, protected from light, 15 - 25° C
|
Shelf Life
|
Ongoing - expected 12 months
|
Extraction
|
Solvent extraction and formulation
|
Origin
|
South Africa
|
Stability Status
|
Conducted according to ICH stability guidelines
Long term studies up to: 24 months (25°C±2°C, 60% ± 5%RH) Accelerated studies up to: 6 months (40°C±2°C, 75% ± 5%RH) |
THC: 25%
THC: 25%
THC: 24%
THC: 22%
THC: 21%
THC: 20%
THC: 20%
* More available on request
THC: 27%
THC: 25%
THC: 24%
THC: 20%
THC: 20%
THC: 20%
THC: 20%
* More available on request